Clinical Trial Update: Sapphire II PRO US Clinical Study [NA]

View source ↗

Summary

The Sapphire II PRO US clinical study sponsored by OrbusNeich has completed. Results were posted on 2018-04-04.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriosclerosis
• Cardiovascular Disease
• Coronary Artery Disease
• Heart Disease
• Myocardial Ischemia

Snippet

Sponsor: OrbusNeich | Conditions: Coronary Artery Disease, Coronary Disease | NA | Status: COMPLETED | Results posted: 2018-04-04